Saccharomyces cerevisiae fungemia after probiotic treatment in an intensive care unit patient

Kara I., YILDIRIM F., Ozgen Ö., Erganis S., Aydogdu M., DİZBAY M., ...Daha Fazla

JOURNAL DE MYCOLOGIE MEDICALE, cilt.28, sa.1, ss.218-221, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28 Sayı: 1
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1016/j.mycmed.2017.09.003
  • Dergi Adı: JOURNAL DE MYCOLOGIE MEDICALE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.218-221
  • Anahtar Kelimeler: Saccharomyces, cerevisiae (boulardii), Fungemia, Probiotic, Intensive care unit, CRITICALLY-ILL, TRANSPLANT RECIPIENTS, BOULARDII, INFECTIONS, SAFETY
  • Gazi Üniversitesi Adresli: Evet

Özet

Saccharomyces cerevisiae is a common colonizer of the human gastrointestinal system as a benign organism. Enteral supplementation of this yeast as a probiotic product is effective in the treatment of antibiotic associated diarrhae. In rare occasions it can cause invasive infections. We present two fungemia cases in an intensive care unit following probiotic treatment containing S. boulardii. We are warning the safety of probiotic treatment in critically ill patients. (C) 2017 Elsevier Masson SAS. All rights reserved.